Gene and cell therapies are gaining steam

More than 4,500 people in the U.S. and Europe have received gene therapies — including CAR-T treatments — according to a new report. That figure could increase dramatically, however. There were more than 1,000 clinical trials for gene therapies underway at the end of 2019, and regenerative medicine trials have room for more than 60,000 patients to enroll around the world.

Notably, financing for the field hit $9.8 billion last year, and the report found that there’s an increase in reimbursements for hospitals that provide costly CAR-T treatments — both indicators that this is a burgeoning field.